
SXTP
USD60 Degrees Pharmaceuticals Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.230
Kõrge
$1.269
Madal
$1.180
Maht
0.12M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
5.0M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.14M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study
Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA)Results obtained using
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study
Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competitionA $5K donation from the Company was split between ILADEF and GLA to recognize the winning nameB-FREE, a Phase
Seotud aktsiad
MMD
MainStay MacKay DefinedTerm Municipal Opportunities Fund
CSWC
Capital Southwest Corporation
BNIX
Bannix Acquisition Corp.
STRS
Stratus Properties Inc.
FTAIP
FTAI Aviation Ltd. 8.25% Fixed to Floating Rate Series A Cumulative Perpetual Redeemable Preferred Shares
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.